European equities traded in the US as American depositary receipts were tracking higher late Tuesday morning, rising 0.46% to 1,966.35 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis (CLLS) and semiconductor company Sequans Communications (SQNS), which advanced 4.7% and 2.6% respectively. They were followed by telecommunications company Nokia (NOK) and medical device maker EDAP TMS (FOCL), which increased 3.2% and 1.3% respectively.

The decliners from continental Europe were led by brewing company Anheuser-Busch InBev (BUD) and biopharmaceutical company DBV Technologies (DBVT), which dropped 3.1% and 1% respectively. They were followed by consumer goods company Unilever (UL) and pharmaceutical company Novo Nordisk (NVO), which were off 0.9% and 1% respectively.

The gainers from the UK were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which surged 27% and 8% respectively. They were followed by biotech company Trinity Biotech (TRIB) and biopharmaceutical company Akari Therapeutics (AKTX), which rose 3.5% and 1% respectively.

The decliners from the UK were led by pharmaceutical company Silence Therapeutics (SLN) and alcoholic beverage company Diageo (DEO), which fell 2% and 1.7% respectively. They were followed by insurance firm Prudential (PUK), which was down 2.1%.